The Global Pulmonary Drugs Market Size Was Valued at USD 61.10 Billion in 2023 and is Projected to Reach USD 108.60 Billion by 2032, Growing at a CAGR of 6.60% From 2024-2032. The Pulmonary Drugs market focuses on the development, clinical testing, and commercialization of pharmacological treatments designed to manage and treat diseases affecting the respiratory system. These medications...